ESMO Highlights Webinar 2025

December 12, 2025 - 7:00 a.m. MT

Global Perspectives on the Latest ESMO Data

Course Description

IASLC’s Education Committee presents a one-hour webinar offering a concise and comprehensive overview of the most significant studies and emerging data on thoracic malignancies presented at the 2025 ESMO (European Society for Medical Oncology) Congress. Expert faculty will highlight key clinical findings, discuss their implications for practice, and provide context on how the latest research may shape the future of lung cancer care worldwide.

Faculty and Speakers

To Be Determined

Name

Credentials

Role and Presentation Title

Name

Credentials

Role and Presentation Title

Name

Credentials

Role and Presentation Title

Name

Credentials

Role and Presentation Title

Name

Credentials

Role and Presentation Title

Name

Credentials

Role and Presentation Title

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). The International Association for the Study of Lung Cancer is accredited by the ACCME to provide continuing medical education for physicians.

 

Credit Designation Statements:

 

Physicians

The International Association for the Study of Lung Cancer designates the live and enduring activity for a maximum of 1 AMA PRA Category 1 Credits™ . Physicians should only claim credit commensurate with the extent of their participation in the activity.

 

Nurse Practitioners and Registered Nurses
For the purpose of recertification, the American Nurses Credentialing Center accepts AMA PRA Category 1 Credit™ issued by organizations accredited by the ACCME (Accreditation Council for Continuing Medical Education).

 

Physician Associates
The National Commission on Certification of Physician Associates (NCCPA) states that the AMA PRA Category 1 Credits™ are acceptable for continuing medical education requirements for recertification.

 

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to:

 

1 MOC point in the American Board of Internal Medicine (ABIM) Maintenance of Certification (MOC) program; and
1 MOC point in the American Board of Pathology (ABPath) Continuing Certification program (Lifelong Learning (CME)
1 MOC point (Self Assessment) in the American Board of Thoracic Surgery (ABTS) Maintenance of Certification (MOC) program

 

It is the CME Activity provider's responsibility to submit participant completion information to ACCME for the purpose of recognizing participation.

Check Out Upcoming Events

Access Past IASLC Webinars

Discover Upcoming IASLC Conferences

Connect With Peers Around the World

Facebook iconX iconInstagram iconLinkedIn icon

The information presented is that of the contributing faculty and does not necessarily represent the views of the International Association for the Study of Lung Cancer and/or any named commercial entity providing financial support. Specific therapies discussed may not be approved and/or specified for use as indicated by the faculty presenters. Therefore, before prescribing any medication, please review the complete prescribing information, including indications, contraindications, warnings, precautions, and adverse effects.

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Powered By